| Market Cap | 18Cr 24Cr 21Cr 20Cr 34Cr 2.28TCr 34Cr 236.08Cr 91Cr 1.16TCr 89Cr 87Cr 3.73TCr | P/E 2024 |
43.4x | P/E 2025 | -109x |
|---|---|---|---|---|---|
| Enterprise Value | 18Cr 24Cr 21Cr 20Cr 34Cr 2.28TCr 34Cr 236.13Cr 91Cr 1.16TCr 89Cr 87Cr 3.73TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 11/20/11 | Killik & Co. LLP : - Form 8.3 - Cello Health Plc | PR |
| 28/20/28 | Cello Health : Form 8.3 - - (HHL) | AQ |
| 10/20/10 | Premier Miton Group Plc : - Form 8.3 - Cello Health Plc | PR |
| 08/20/08 | Premier Miton Group Plc : - Form 8.3 - Cello Health Plc | PR |
| 07/20/07 | Killik & Co. LLP : - Form 8.3 - Cello Health Plc | PR |
| Manager | Title | Age | Since |
|---|---|---|---|
Rebecca Hyde
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Williams
BRD | Director/Board Member | 51 | 13/08/2020 |
Michael Madden
BRD | Director/Board Member | 47 | 15/12/2023 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 41.25L 54.68L 48.09L 45.48L 77.47L 52Cr 77.92L 5.45Cr 2.1Cr 27Cr 2.05Cr 2.01Cr 86Cr | -16.36L -21.69L -19.07L -18.04L -30.72L -21Cr -30.9L -2.16Cr -83.41L -11Cr -81.42L -79.66L -34Cr |
| Net Debt | 13.41L 17.78L 15.63L 14.78L 25.18L 17Cr 25.33L 1.77Cr 68.37L 8.71Cr 66.74L 65.3L 28Cr | 42T 55.68T 48.97T 46.31T 78.88T 53.45L 79.34T 6L 2L 27.27L 2L 2L 87.64L |
Employees
-
Sector
-
